Related Experiment Video
Updated: Jun 21, 2026
07:02
A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
The time course of drug effects
Hesham S Al-Sallami1, Venkata V Pavan Kumar, Cornelia B Landersdorfer
1School of Pharmacy, University of Otago, Dunedin, New Zealand.
Pharmaceutical Statistics
|July 24, 2009
Summary
This review explains how drug effects change over time. It covers pharmacokinetic, pharmacodynamic, and pharmacokinetic-pharmacodynamic models to understand drug onset, duration, and intensity relative to disease progression.
Area of Science:
- Pharmacology
- Pharmacokinetics
- Pharmacodynamics
Background:
- Understanding the temporal dynamics of drug action is crucial in clinical practice.
- Existing models often focus on concentration-effect relationships, but the time course is complex.
- Integrating drug concentration, effect, and disease progression is essential for optimizing therapy.
Purpose of the Study:
- To introduce fundamental concepts of drug time-effect relationships.
- To present pharmacokinetic, pharmacodynamic, and linked PK/PD models.
- To illustrate how these models explain the time course of drug effects in relation to disease progression.
Main Methods:
- Review of established pharmacokinetic (PK) models.
- Discussion of pharmacodynamic (PD) models.
- Introduction of integrated pharmacokinetic-pharmacodynamic (PK/PD) models.
- Exploration of drug time-effect models with examples.
- Consideration of disease progression models.
Main Results:
- Models for drug concentration over time (PK) and concentration-effect (PD) are presented.
- Linked PK/PD models are introduced to describe the overall time course of drug effects.
- Examples illustrate how models explain drug onset, duration, and maximal effect.
- The interplay between drug effects and disease progression is discussed.
Conclusions:
- Pharmacokinetic-pharmacodynamic modeling provides a framework for understanding drug time-effect relationships.
- These models are essential for predicting and optimizing drug response.
- Integrating drug effects with disease progression enhances therapeutic strategies.
More Related Videos
Related Concept Videos
01:14Time Course of Drug Effect
The progression of a drug's impact can be analyzed by examining both the concentration-time course and the effect-time course. The concentration-time course is determined by the drug's half-life and is influenced by factors such as its pharmacokinetics, including absorption, distribution, metabolism, and elimination. The effect of the drug is often related to its concentration in the plasma and is calculated using the maximum drug effect and the plasma concentration that generates 50 percent of...
01:15Drug Concentration Versus Time Correlation
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the lowest drug...
01:14Pharmacokinetic–Pharmacodynamic Relationship: Duration of Dose-Effect Relationship
For drugs producing a quantal response, onset occurs when plasma concentration reaches a minimum effective level (Cmin). The drug's action duration depends on how long the plasma concentration remains above Cmin.Two primary factors influence this duration: dose size and the rate of drug removal from the action site. Both depend on the drug's redistribution to poorly perfused tissues and elimination processes. A larger dose promotes rapid onset and prolongs the effect's duration.Consider a...
01:28Pharmacokinetic–Pharmacodynamic Relationship: Dose to Pharmacological Effect
A drug’s dosage and pharmacokinetic properties determine how quickly it acts, how intense its effects are, and how long it lasts. Higher doses increase drug concentration at receptor sites, producing a hyperbolic curve when pharmacologic response is plotted against drug dose. Converting this scale to a log-linear format results in a sigmoidal curve, better representing dose–response relationships.For drugs following a one-compartment model, the pharmacologic response is directly proportional to...
01:23Pharmacokinetic–Pharmacodynamic Relationship: Influence of Elimination Half-Life on Effect Duration
Drug elimination from the body primarily occurs through metabolic and excretion pathways. Hepatic metabolism transforms lipophilic drugs into hydrophilic forms for excretion, typically via enzymatic processes classified as phase I (modification) and phase II (conjugation). Renal excretion eliminates drugs and metabolites through filtration and secretion in the kidneys. Impairment in liver or kidney function can hinder these processes, delaying drug clearance and extending the drug’s half-life.
01:17Kinetics of Drug Elimination
Eliminating drugs from the body is a vital process that occurs through excretion or metabolism. Understanding the kinetics of drug elimination is crucial for drug development, dosage determination, and optimizing patient outcomes.
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...
Drug clearance depends on the rate of drug elimination and its plasma concentration. Another important parameter is the half-life of a drug, which is the time required for its concentration to decrease by half. In most cases, drug clearance follows first-order...